Partner Headlines - LLY

  1. Eli Lilly Shares Go Parabolic

    Benzinga
  2. Stocks Cling To Thin Early Gains; Ambarella Bounces, Cree Dives

    IBD
  3. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD
  4. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The ...

    GuruFocus
  5. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD
  6. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  7. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  8. Benzinga's Top Initiations

    Benzinga
  9. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus
  10. New Migraine Drugs Could Ease Investors' Headaches

    IBD
  11. What We Don't Know About Antibiotics Could Kill Us

    FoxBusiness
  12. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD
  13. 4 Stocks Rising On ASCO Cancer Drug News

    IBD
  14. Bristol Sinks On Lung Cancer Data; Merck Up On 2 Trials

    IBD
  15. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase ...

    Benzinga
  16. Lilly to Present New Clinical Data at 75th American Diabetes ...

    Benzinga
  17. Amgen Down After Suicides Kill AstraZeneca Deal

    IBD
  18. IPO Stock Watch: Alder Soars On Migraine Drug Results

    IBD
  19. Vanguard Adds to Four of Its Largest Stakes

    GuruFocus
  20. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus
  21. 8 Dividend Stocks With The Right Qualities

    GuruFocus
  22. MannKind Looks Good For Long Term Investors

    GuruFocus
  23. Citigroup Upgrades Eli Lilly To Buy

    Benzinga
  24. Novartis EPS beats the Street

    IBD
  25. Eli Lilly

    IBD
  26. US Stock Futures Down Ahead Of Earnings, Economic Data

    Benzinga
  27. Eli Lilly Tops Q1 Views

    Benzinga
  28. Eli Lilly Partner Deciphera Pharma Announces Data Highlighting ...

    Benzinga
  29. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD
  30. 5 'Key Pipeline Catalysts' To Watch At Eli Lilly

    Benzinga
  31. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD
  32. IPO Alert: Biotech Investors Should Watch Advanced Accelerator's ...

    Benzinga
  33. UBS: Eli Lilly's 'Outlook Continuing To Improve'

    Benzinga
  34. Eli Lilly CEO Explains The Reasons Behind Not Changing 2015 Guidance ...

    Benzinga
  35. Viekira Pak View Falls Short

    IBD
  36. AbbVie Beats, But Stock Falls; Lilly Cuts Guidance

    IBD
  37. UPDATE: Eli Lilly Posts Upbeat Q4 Profit, Sales Decline

    Benzinga
  38. Earnings Scheduled For January 30, 2015

    Benzinga
  39. 10 Must Watch Stocks for Today

    Benzinga
  40. Box Ready To Unwrap IPO In Hot Online Storage Field

    IBD
  41. Feeling Good With This Med Company

    GuruFocus
  42. Eli Lilly

    IBD
  43. Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants

    Benzinga
  44. 10 Biotech Stories You Might've Missed This Week

    Benzinga
  45. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  46. Exclusive: JPMorgan Chase CEO Jamie Dimon Talks Cancer Recovery, ...

    FoxBusiness
  47. Eil Lilly CEO Talks New Product Launches, Pricing Pressure From ...

    Benzinga
  48. FDA Issues Import Block On Eli Lilly's Cialis

    Benzinga
  49. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  50. Deutsche Bank, Stifel Differ On Outlook For Eli Lilly

    Benzinga
  51. Benzinga's Top Upgrades

    Benzinga
  52. Jefferies Upgrades Eli Lilly To Buy

    Benzinga
  53. UPDATE: Deutsche Bank Downgrades Eli Lilly On Positive Outlook, ...

    Benzinga
  54. Eli Lilly

    IBD
  55. Alkermes Hits High On Schizophrenia Drug Results

    IBD
  56. Eli Lilly Moves Higher Following FY 2014 & 2015 Outlook

    Benzinga
  57. Benzinga's Top #PreMarket Losers

    Benzinga
  58. Fast Money Halftime Report Final Trade From January 6

    Benzinga
  59. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga
  60. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  61. 7 Stocks You Should Be Watching Today

    Benzinga
  62. Eli Lilly

    IBD
  63. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  64. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD
  65. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  66. Zosano Pharma and Eli Lilly and Company Enter Into Exclusive ...

    Benzinga
  67. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  68. Screening Pharma Stocks Amid Turnaround

    YCharts
  69. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  70. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  71. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  72. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  73. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  74. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  75. Earnings Scheduled For October 23, 2014

    Benzinga
  76. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  77. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  78. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  79. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  80. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  81. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  82. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  83. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  84. Meet 5 Top International Stocks Not Based In China

    IBD
  85. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  86. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  87. Drug giants target Alzheimer's

    IBD
  88. What Is A High Risk Market?

    Benzinga
  89. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  90. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  91. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  92. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  93. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  94. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  95. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  96. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  97. Thursday Morning Earnings Reports

    Benzinga
  98. Earnings Scheduled For July 24, 2014

    Benzinga
  99. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  100. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!